Loading organizations...
Triathlon Medical Ventures is a venture capital firm providing equity capital to early and expansion-stage companies within life sciences, biomedical, and healthcare sectors. It invests in innovative medical solutions, including drug discovery and medical equipment, backing enterprises poised to address significant unmet medical needs and demonstrate strong market potential.
Established in 2004, Triathlon Medical Ventures was co-founded by Dennis B. Costello, a Managing Partner. The firm's inception stemmed from insights into substantial opportunities within the evolving medical technology and therapeutic landscape. Suzette Dutch, also a Managing Partner, contributes leadership in identifying and nurturing promising ventures in specialized healthcare markets.
The firm partners with nascent and growth-oriented companies to foster novel therapies and advanced medical devices. Triathlon Medical Ventures’ long-term vision focuses on advancing medical science by strategically supporting enterprises that can deliver transformative healthcare solutions and achieve market leadership.
Triathlon Medical Ventures has 11 tracked investments across 6 companies. The latest tracked deal is $37.0M Series C in CoLucid Pharmaceuticals in January 2015.